1-3 of 3
S. Kleinknecht
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Modulating Effects of Low Doses of Cyclophosphamide and Keyhole Limpet Hemocyanine on Peripheral Blood Immune Parameters in Patients with Metastatic Renal Cell Carcinoma

Available to Purchase
Subject Area:
Further Areas
S. Kleinknecht, K.-H. Bichler, W.L. Strohmaier
Journal: Urologia Internationalis
Urol Int (1992) 48 (1): 1–8.
https://doi.org/10.1159/000282287
Published Online: 03 February 2010
View article titled, Immune Modulating Effects of Low Doses of Cyclophosphamide and Keyhole Limpet Hemocyanine on Peripheral Blood Immune Parameters in Patients with Metastatic Renal Cell Carcinoma
Open the PDF for Immune Modulating Effects of Low Doses of Cyclophosphamide and Keyhole Limpet Hemocyanine on Peripheral Blood Immune Parameters in Patients with Metastatic Renal Cell Carcinoma in another window
Journal Articles

Investigations on Bone Metabolism of Urological Tumors Forming Metastases

Available to Purchase
Subject Area:
Further Areas
K.-H. Bichler, E. Petri, A. Hub, S. Kleinknecht, A. Heidenreich
Journal: Urologia Internationalis
Urol Int (1996) 56 (2): 61–68.
https://doi.org/10.1159/000282813
Published Online: 03 February 2010
View article titled, Investigations on Bone Metabolism of Urological Tumors Forming Metastases
Open the PDF for Investigations on Bone Metabolism of Urological Tumors Forming Metastases in another window
Journal Articles

Immune Status and Immune Therapy of Renal Cell Carcinoma

Available to Purchase
Subject Area:
Further Areas
K.-H. Bichler, S. Kleinknecht, W.L. Strohmaier
Journal: Urologia Internationalis
Urol Int (1990) 45 (5): 269–283.
https://doi.org/10.1159/000281720
Published Online: 02 February 2010
View article titled, Immune Status and Immune Therapy of Renal Cell Carcinoma
Open the PDF for Immune Status and Immune Therapy of Renal Cell Carcinoma in another window